Loading
The validation of a 40-gene test in high-risk squamous cell skin cancer, which separated three groups by their chance of spread.
Three-year metastasis-free survival rates were 91.4, 80.6 and 44.0 per cent for classes 1, 2A and 2B.
A risk class exists; whether acting on it improves outcomes is not shown, and Medicare does not cover it.
Shares DecisionDx-SCC, Gene-expression prognostic assays, Cutaneous squamous cell carcinoma.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/